FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385667360> ?p ?o ?g. }

• W4385667360 endingPage "e193255f" @default.
• W4385667360 startingPage "e193255f" @default.
• W4385667360 abstract "Topic: 22. Stem cell transplantation - Clinical Background: Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is used to treat various blood diseases. Glomerular diseases after allo-HSCT are rare, and the most common disease is membranous nephropathy (MN) after allo-HSCT. The occurrence of MN is often accompanied by the clinical manifestations of cGVHD. In previous studies, the most common types of antibodies deposited in MNs after allo-HSCT were IgG1 and IgG4. Unlike primary MN, MN after allo-HSCT rarely represents a positive result for the PLA2R antibody. The main clinical manifestation of MN after allo-HSCT is an increase in urinary protein. Patients often seek medical treatment due to urinary protein or hypoalbuminemia. Symptomatic treatment, glucocorticoids and/or immunosuppressants (tacrolimus, cyclosporin, mycophenolate mofetil, rituximab, etc.) are given according to the severity of MN and the condition of the patients Aims: To describe the risk factors and outcomes of membranous nephropathy after allogeneic haematopoietic stem cell transplantation. Methods: In this retrospective study, we collected data from 29 cases of MN after allo-HSCT as diagnosed in our hospital and 1:3 matched a control group with the time of allo-HSCT as a reference. We collected the detailed HSCT information, laboratory examination results, renal pathological results, treatment methods and therapeutic effects from these patients to describe the risk factors, clinical characteristics and outcomes of membranous nephropathy after allo-HSCT. Results: In the univariate analysis, the age of the patient (P=.008), MDS (P=.045), HLA-matched related donor (MRD) (P=.001), HLA-matched unrelated donor (MUD) (P=.012), and history of cGVHD (P=.015) were the risk factors for MN after allo-HSCT. In the multivariate analysis, the risk factors for MN after transplantation were MRD (P=.001), MUD (P=.017), and history of cGVHD (P=.039). A detailed renal pathology was available in 26 of 29 patients. IgA, IgG, IgM, C1q, C3 and FRA immune deposits were detected in the glomerulus, among which IgG was the predominant immune deposit, with 19 patients presenting 3+ and 7 patients presenting 2+. IgG1 was the main IgG subtype, with 6 patients presenting 3+ and 10 patients presenting 2+, while IgG2, IgG3, and IgG4 could also be detected in some patients. In electron microscope pathology, the deposition sites of electronically dense substances of the glomerulus included the subepithelial, mesangium, subendothelial and basement membrane areas, among which the most common deposition site of electronically dense substances was the subcutaneous glomerulus. Four patients also presented with immune complex deposition in the renal tubules. The treatments for MN after transplantation included symptomatic treatment (sodium and water intake restriction, albumin, etc.), glucocorticoids and/or immunosuppressants (tacrolimus, cyclosporin, mycophenolate mofetil, rituximab, methotrexate, etc.). Thirteen of 29 patients achieved complete remission, 9 of 29 patients achieved partial remission, and 7 of 29 patients had no response to treatment. All the patients survived through the last follow-up. Summary/Conclusion: In this study, we analysed the risk factors for membranous nephropathy after allogeneic haematopoietic stem cell transplantation for the first time and described the clinical characteristics, treatment and outcomes. Keywords: Risk factor, Renal impairment, Allogeneic hematopoietic stem cell transplant, Outcome" @default.
• W4385667360 created "2023-08-09" @default.
• W4385667360 creator A5001508669 @default.
• W4385667360 creator A5002188808 @default.
• W4385667360 creator A5011029344 @default.
• W4385667360 creator A5013296641 @default.
• W4385667360 creator A5020289063 @default.
• W4385667360 creator A5038357890 @default.
• W4385667360 creator A5043041637 @default.
• W4385667360 creator A5044717310 @default.
• W4385667360 creator A5046348283 @default.
• W4385667360 creator A5046424825 @default.
• W4385667360 creator A5051030924 @default.
• W4385667360 creator A5051211027 @default.
• W4385667360 creator A5061407928 @default.
• W4385667360 creator A5065894155 @default.
• W4385667360 creator A5072208411 @default.
• W4385667360 creator A5078632164 @default.
• W4385667360 creator A5079594267 @default.
• W4385667360 creator A5081098041 @default.
• W4385667360 creator A5081663648 @default.
• W4385667360 creator A5084854649 @default.
• W4385667360 creator A5087610827 @default.
• W4385667360 date "2023-08-01" @default.
• W4385667360 modified "2023-09-22" @default.
• W4385667360 title "P1312: CHARACTERISTICS OF MEMBRANOUS NEPHROPATHY AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION" @default.
• W4385667360 doi "https://doi.org/10.1097/01.hs9.0000972136.19325.5f" @default.
• W4385667360 hasPublicationYear "2023" @default.
• W4385667360 type Work @default.
• W4385667360 citedByCount "0" @default.
• W4385667360 crossrefType "journal-article" @default.
• W4385667360 hasAuthorship W4385667360A5001508669 @default.
• W4385667360 hasAuthorship W4385667360A5002188808 @default.
• W4385667360 hasAuthorship W4385667360A5011029344 @default.
• W4385667360 hasAuthorship W4385667360A5013296641 @default.
• W4385667360 hasAuthorship W4385667360A5020289063 @default.
• W4385667360 hasAuthorship W4385667360A5038357890 @default.
• W4385667360 hasAuthorship W4385667360A5043041637 @default.
• W4385667360 hasAuthorship W4385667360A5044717310 @default.
• W4385667360 hasAuthorship W4385667360A5046348283 @default.
• W4385667360 hasAuthorship W4385667360A5046424825 @default.
• W4385667360 hasAuthorship W4385667360A5051030924 @default.
• W4385667360 hasAuthorship W4385667360A5051211027 @default.
• W4385667360 hasAuthorship W4385667360A5061407928 @default.
• W4385667360 hasAuthorship W4385667360A5065894155 @default.
• W4385667360 hasAuthorship W4385667360A5072208411 @default.
• W4385667360 hasAuthorship W4385667360A5078632164 @default.
• W4385667360 hasAuthorship W4385667360A5079594267 @default.
• W4385667360 hasAuthorship W4385667360A5081098041 @default.
• W4385667360 hasAuthorship W4385667360A5081663648 @default.
• W4385667360 hasAuthorship W4385667360A5084854649 @default.
• W4385667360 hasAuthorship W4385667360A5087610827 @default.
• W4385667360 hasBestOaLocation W43856673601 @default.
• W4385667360 hasConcept C126322002 @default.
• W4385667360 hasConcept C144301174 @default.
• W4385667360 hasConcept C203014093 @default.
• W4385667360 hasConcept C2775946357 @default.
• W4385667360 hasConcept C2777408962 @default.
• W4385667360 hasConcept C2779338263 @default.
• W4385667360 hasConcept C2779561371 @default.
• W4385667360 hasConcept C2780091579 @default.
• W4385667360 hasConcept C2780653079 @default.
• W4385667360 hasConcept C28328180 @default.
• W4385667360 hasConcept C2909675724 @default.
• W4385667360 hasConcept C2911091166 @default.
• W4385667360 hasConcept C38180746 @default.
• W4385667360 hasConcept C54355233 @default.
• W4385667360 hasConcept C71924100 @default.
• W4385667360 hasConcept C86803240 @default.
• W4385667360 hasConcept C90924648 @default.
• W4385667360 hasConceptScore W4385667360C126322002 @default.
• W4385667360 hasConceptScore W4385667360C144301174 @default.
• W4385667360 hasConceptScore W4385667360C203014093 @default.
• W4385667360 hasConceptScore W4385667360C2775946357 @default.
• W4385667360 hasConceptScore W4385667360C2777408962 @default.
• W4385667360 hasConceptScore W4385667360C2779338263 @default.
• W4385667360 hasConceptScore W4385667360C2779561371 @default.
• W4385667360 hasConceptScore W4385667360C2780091579 @default.
• W4385667360 hasConceptScore W4385667360C2780653079 @default.
• W4385667360 hasConceptScore W4385667360C28328180 @default.
• W4385667360 hasConceptScore W4385667360C2909675724 @default.
• W4385667360 hasConceptScore W4385667360C2911091166 @default.
• W4385667360 hasConceptScore W4385667360C38180746 @default.
• W4385667360 hasConceptScore W4385667360C54355233 @default.
• W4385667360 hasConceptScore W4385667360C71924100 @default.
• W4385667360 hasConceptScore W4385667360C86803240 @default.
• W4385667360 hasConceptScore W4385667360C90924648 @default.
• W4385667360 hasIssue "S3" @default.
• W4385667360 hasLocation W43856673601 @default.
• W4385667360 hasLocation W43856673602 @default.
• W4385667360 hasOpenAccess W4385667360 @default.
• W4385667360 hasPrimaryLocation W43856673601 @default.
• W4385667360 hasRelatedWork W1178830380 @default.
• W4385667360 hasRelatedWork W1565849830 @default.
• W4385667360 hasRelatedWork W2736344059 @default.
• W4385667360 hasRelatedWork W2884628875 @default.
• W4385667360 hasRelatedWork W2928391107 @default.
• W4385667360 hasRelatedWork W3113098492 @default.

• next